跳至主要内容
临床试验/NCT00180908
NCT00180908已完成3 期

SFOP-OS94: Multicentric Randomised Phase III Trial Comparing Efficacy of Preoperative High-Dose Methotrexate Plus Doxorubicin to Efficacy of High-Dose Methotrexate Plus Etoposide and Ifosfamide, in Children and Adolescents Osteosarcoma

Gustave Roussy, Cancer Campus, Grand Paris2 个研究点 分布在 1 个国家目标入组 226 人开始时间: 1994年6月最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
226
试验地点
2
主要终点
Good histological response (5% or less viable cells) after preoperative chemotherapy

研究概览

简要总结

The purpose of this study is to compare two preoperative chemotherapy regimens based on high-dose methotrexate courses given alternately either with doxorubicin or with etoposide-ifosfamide.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
— 至 20 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • non metastatic limb osteosarcoma,
  • age less than 20 years,
  • biopsy proven high-grade osteosarcoma,
  • no previous treatment,
  • no contraindication to chemotherapy
  • no previous malignancy,
  • Written informed consent.

排除标准

  • juxta-cortical sarcoma and microcellular anaplastic sarcoma,
  • previous anticancer treatment
  • contraindication to chemotherapy
  • previous malignancy,

结局指标

主要结局

Good histological response (5% or less viable cells) after preoperative chemotherapy

次要结局

  • Event-free survival,
  • Overall survival,
  • Toxicity.

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验